指南与共识心力衰竭与心肌病

印度喀拉拉邦急性心衰登记:指南导向药物治疗依从性差

The Cardiology Society of India-Kerala Acute Heart Failure Registry: poor adherence to guideline-directed medical therapy.
指南 / 共识 · Eur Heart J · 2021-12-21

该研究基于印度喀拉拉邦50家医院的观察性登记,纳入7507例急性心衰患者,评估指南导向药物治疗(GDMT)处方模式与90天死亡率。结果显示住院死亡率为7%、90天死亡率为11.6%,仅28%的射血分数降低心衰患者接受GDMT,且GDMT各组分处方与90天死亡率独立相关。

要点

  • 急性心衰患者住院死亡率为7%,90天死亡率为11.6%。
  • 射血分数降低心衰患者中仅28%接受指南导向药物治疗。
  • GDMT各组分处方与90天死亡率独立相关。

核心结论

  • 急性心衰患者住院和90天死亡率分别为7%和11.6%,仅四分之一患者接受GDMT,GDMT启动与死亡率独立相关。

研究设计与样本

  • 印度喀拉拉邦50家医院的前瞻性观察性登记,连续纳入同意参与的急性心衰患者,采用2016年欧洲心脏病学会标准诊断,共7507例(37%女性),平均年龄64.3(12.9)岁。

主要发现

  • 超过三分之二(67.5%)患者为射血分数降低心衰。
  • 射血分数降低心衰患者中仅28%接受GDMT。
  • 住院死亡率为7%,90天死亡率为11.6%。
  • GDMT各组分处方与90天死亡率独立相关。

关键数值与推荐

  • 采用2016年欧洲心脏病学会标准诊断急性心衰。
  • 使用Kaplan-Meier生存分析和Cox比例风险模型,多变量模型纳入MAGGIC风险评分变量。

临床怎么用

  • 应关注提高急性心衰患者GDMT处方率,可能改善生存。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIMS: Data on the burden of acute heart failure (AHF) admissions, practice patterns, and outcomes are rare from India and other low- and middle-income countries. We aimed to describe the baseline characteristics, guideline-directed medical therapy (GDMT) prescribing patterns and 90-day mortality rates in patients admitted with AHF in Kerala, India. METHODS AND RESULTS: The Cardiology Society of India-Kerala Acute Heart Failure Registry (CSI-KHFR) is an observational registry from 50 hospitals in Kerala, India, with prospective follow-up. Consecutive patients with AHF, who consented to participate, were enrolled. The 2016 European Society of Cardiology criteria were used for the diagnosis of AHF. Kaplan-Meier survival analysis and Cox-proportional hazard models were used for data analysis. The variables in the MAGGIC risk score were used in the multivariable model. A total of 7507 patients with AHF (37% female) participated in the CSI-KHFR. The mean age was 64.3 (12.9) years. More than two-third had reduced ejection fraction (EF) (67.5%). Nearly one-fourth (28%) of patients with heart failure (HF) with reduced EF received GDMT. Overall, in-hospital and 90-day mortality rates were 7% and 11.6%, respectively. Prescriptions of different components of GDMT were independently associated with 90-day mortality. CONCLUSION: The CSI-KHFR recorded an in-hospital and 90-day mortality of 7% and 11.6%, respectively. Only one of four patients received GDMT. AHF mortality was independently associated with GDMT initiation. Quality improvement initiatives that focus on increasing GDMT prescription may improve the survival of HF patients in India.

来源:Eur Heart J,查看原文。版权归原作者所有。

引用

  1. Joseph, Panniyammakal, Abdullakutty, et al. The Cardiology Society of India-Kerala Acute Heart Failure Registry: poor adherence to guideline-directed medical therapy. Eur Heart J. 2021. PMID: 34931232. doi:10.1093/eurheartj/ehab793

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。